PROSPECTS AND OPPORTUNITIES
Rise in ageing population continues to drive growth
Over the forecast period, volume and value sales are expected to continue to rise in Rx/reimbursement adult incontinence, albeit gradually slowing down. The continued rise in sales will mainly be due to the increasing number of older consumers staying in their homes amid rising life expectancy.
Little innovation expected as money is tight due to political climate
Little innovation is expected over the early to mid-forecast period as money is tight and companies are not investing in developing new products due to the uncertainties linked to the Israel-Hamas war. Should the war finish around 2026, then companies may feel more confident about starting to innovate once again.
Distribution via pharmacies likely to be the main channel
Distribution via pharmacies that have particular contracts with the HMO’s will continue to distribute Rx/reimbursement adult incontinence pads. This is unlikely to change over the forecast period.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Israel with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Israel, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Rx/Reimbursement adult incontinence in Israel report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Rx/Reimbursement adult incontinence in Israel?
- Which are the leading brands in Rx/Reimbursement adult incontinence in Israel?
- How are products distributed in Rx/Reimbursement adult incontinence in Israel?
- How is the rise of e-commerce changing the retail and competitive landscape?
- How has COVID-19 impacted demand? Where have sales increased due to stockpiling amidst national lockdown?
- How have enforced home seclusion and social distancing measures following COVID-19 changed usage patterns for Rx/Reimbursement adult incontinence products?
- Where is future growth expected to be most dynamic?
- How important will sustainability and recycling be in generating future growth?
Rx/Reimbursement Adult Incontinence in Israel - Category analysis
KEY DATA FINDINGS
Rx/reimbursement products bought with welfare allowance
Rise in 64+ population drives growth of Rx/reimbursement products.
Distribution via pharmacies is the norm
Rise in ageing population continues to drive growth
Little innovation expected as money is tight due to political climate
Distribution via pharmacies likely to be the main channel
Tissue and Hygiene in Israel - Industry Overview
Tissue and hygiene in 2024: The big picture
2024 key trends
Competitive landscape
Retail developments
What next for tissue and hygiene?
DISCLAIMER
Rx/Reimbursement adult incontinence
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!